Financhill
Back

Atara Biotherapeutics Vs. Corvus Pharmaceuticals Industry Stock Comparison

Sell
37

ATRA
Atara Biotherapeutics

Last Price:
$11.27
Seasonality Move:
4.11%
Sell
12

CRVS
Corvus Pharmaceuticals

Last Price:
$5.04
Seasonality Move:
-9.57%
Sell
37
Atara Biotherapeutics (ATRA) is a Sell

Is Atara Biotherapeutics a Buy, Sell or Hold?

  • The current Atara Biotherapeutics [ATRA] share price is $11.40. The Score for ATRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ATRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
12
Corvus Pharmaceuticals (CRVS) is a Sell

Is Corvus Pharmaceuticals a Buy, Sell or Hold?

  • The current Corvus Pharmaceuticals [CRVS] share price is $5.00. The Score for CRVS is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • CRVS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ATRA Stock Price Chart

What is Atara Biotherapeutics's stock price today?

  • The Atara Biotherapeutics share price today is $11.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRA is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRVS Stock Price Chart

What is Corvus Pharmaceuticals's stock price today?

  • The Corvus Pharmaceuticals share price today is $5.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRVS is experiencing slight selling pressure.

ATRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 51.71 Buy
Chaikin Money Flow: 138596 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.63 - 12.55) Sell
Bollinger Bands (100): (7.42 - 11.18) Buy

CRVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 28.05 Sell
Chaikin Money Flow: -296242 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.66 - 9.1) Sell
Bollinger Bands (100): (4.21 - 8.29) Sell

ATRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.65 Buy
20-day SMA: 11.71 Sell
50-day SMA: 10.72 Buy
200-day SMA: 11.74 Sell
8-day EMA: 10.84 Buy
20-day EMA: 11.22 Buy
50-day EMA: 10.77 Buy
200-day EMA: 14.19 Sell

CRVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.58 Sell
20-day SMA: 7.75 Sell
50-day SMA: 8.03 Sell
200-day SMA: 4.09 Buy
8-day EMA: 6.24 Sell
20-day EMA: 7.25 Sell
50-day EMA: 7.37 Sell
200-day EMA: 4.95 Buy

Atara Biotherapeutics Earnings Growth & ATRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $11.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $61.17 per share, and a decrease next year of $10.45 per share.

Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.

Atara Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corvus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):